ImmusanT, a biotechnology company out of Massachusetts is working on developing Nexxax2, a vaccine which could potentially treat or prevent celiac disease. As of this week, they finished the Phase 1 b trial. This means that we are now closer than ever to finding some sort of “cure” or treatment for celiac beyond the dietary […]
Chloe is a senior at University of Maine Orono studying Mass Communication and Political Science. In addition to writing for BDN, she is the Editor-in-Chief of Her Campus UMaine. She has known about her Celiac Disease for a little over a year and has been eating gluten free as well as sometimes dairy-free. She is from Chebeague Island, Maine, where she grew up, but has also lived in Cleveland, Ohio and Blagoevgrad, Bulgaria in addition to Orono.